Isthmus Partners’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-26,856
Closed -$4.68M 148
2021
Q4
$4.68M Sell
26,856
-15,969
-37% -$2.66M 0.79% 46
2021
Q3
$7.09M Buy
42,825
+1,071
+3% +$184K 1.29% 41
2021
Q2
$7.51M Buy
41,754
+1,578
+4% +$288K 1.32% 41
2021
Q1
$7.75M Buy
40,176
+515
+1% +$99.1K 1.42% 42
2020
Q4
$8.01M Buy
39,661
+432
+1% +$89.4K 1.62% 31
2020
Q3
$8.24M Buy
39,229
+29
+0.1% +$6.46K 1.93% 19
2020
Q2
$8.6M Sell
39,200
-4,338
-10% -$867K 2.12% 9
2020
Q1
$7.54M Sell
43,538
-7,471
-15% -$1.23M 2.32% 8
2019
Q4
$7.83M Buy
51,009
+3,412
+7% +$510K 1.78% 30
2019
Q3
$7.23M Sell
47,597
-325
-0.7% -$51.4K 1.71% 30
2019
Q2
$7.34M Buy
+47,922
New +$7.32M 1.75% 25

Other funds holding CLX

Isthmus Partners's CLX Position: Q1 2022 in Review

Isthmus Partners sold out of Clorox (CLX) in Q1 2022, closing a stake of 26,856 shares — an estimated $4.68M sold.

Isthmus Partners first reported a position in CLX in Q2 2019 and held it in 11 quarters. The position peaked at $8.6M in Q2 2020. 1,095 funds tracked by Wall St. Rank hold CLX as of Q1 2022.

  • Isthmus Partners reported no remaining Clorox position as of Q1 2022 after selling out during the quarter.
  • Isthmus Partners sold 26,856 Clorox shares in Q1 2022, an estimated $4.68M.
  • Isthmus Partners first reported a position in Clorox in Q2 2019 and held it in 11 quarters.
  • Isthmus Partners's Clorox position peaked at $8.6M in Q2 2020.
  • 1,095 funds tracked by Wall St. Rank held Clorox as of Q1 2022.

Based on Isthmus Partners's 13F filing for Q1 2022, filed 4 May 2022.